Additionally, SIRT1 inhibits caspase-3 activation by inhibiting Bax via PGC-1α [22, 23], suggesting that SIRT1 may affect the onset and progression of HCC through mitochondria-regulated GSDME-dependent pyroptosis. Here, SIRT1 is linked to hepatocellular carcinoma.